Looks like all they need is positive data from phase 2 and phase 3 trials involving several hundred patients and hundreds of millions of dollars, in an indication where all other drugs have failed.
still, it’s a step forward that they have manufactured some, although stability is not yet demonstrated.
I reckon a 5% chance of hitting the market in 10 years. But what do I know?
Ann: PRENUMBRA formulation completed for clinical trial use, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.30 |
Change
0.000(0.00%) |
Mkt cap ! $716.1M | |||
| Open | High | Low | Value | Volume |
| $14.21 | $14.33 | $13.69 | $2.607M | 186.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 658 | $14.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.32 | 698 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |